What is the efficacy of guideline-conforming treating of rhinoconjunctivitis?;Was bewirkt leitlinienkonforme therapie in der behandlung der allergischen rhinokonjunktivitis?

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 30, 2008, Pages

  Köberlein, Juliane ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Allergic rhinoconjunctivitis; Guideline confirming treating; Therapy compliance

Indexed keywords

ANGIOTENSIN; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; IMMUNOMODULATING AGENT; LEVOCETIRIZINE; LORATADINE; PLACEBO;

DRUG EFFICACY; HUMAN; HYPERSENSITIVITY; IMMUNOTHERAPY; PRACTICE GUIDELINE; REVIEW; RHINOCONJUNCTIVITIS; ALLERGIC CONJUNCTIVITIS; ECONOMICS; GERMANY; HAY FEVER; PATIENT COMPLIANCE; PERENNIAL RHINITIS; QUALITY OF LIFE; STANDARD;

CONJUNCTIVITIS, ALLERGIC; GERMANY; GUIDELINE ADHERENCE; HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 48549098955     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067325     Document Type: Review

References (30)

1. ARIA At-A-Glance Pocket Reference www.whiar.org; Zugriff:8.12.2007
2. AWMF. Die nasale Hyperaktivität. Die allergische Rhinitis und ihre Differenzialdiagnosen. Konsensusbericht zur Pathophysiologie, Klassifikation, Diagnose und Therapie. online Nr. 017/058; 1996
3. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743
4. Bachert C, Borchard U, Wedi B, Klimek L, Rasp G, Riechelmann H, Schultze-Werninghaus G, Wahn U, Ring J. Leitlinie der DGAI zur allergischen Rhinokonjunktivitis. Allergologie 2003; 26: 147-162
5. Bachert C, Lange B, Virchow JC. Asthma und allergische Rhinitis. Eine Erkrankung mit zwei Gesichtern. Stuttgart: Thieme, 2005
6. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005; 60: 350-353
7. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24: 758-764
8. Bousquet J. Allergic rhinitis and its impact on asthma. Vienna: In: XXV EAACI Congress, 2006
9. Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, El Hasnaoui A, Chanal I. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005; 35: 728-732
10. Bousquet J, Lund VJ, van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT, El-Akkad T. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003; 58: 733-741
11. Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, Allaf B. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006; 117: 158-162
12. Bousquet J, van Cauwenberge P, Ait Khaled N et al. (2006) Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy 2006; 61: 1086-1096
13. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and the impact of asthma (ARIA). Executive Summary. Allergy 2002; 57: 841-855
14. Bousquet J, Van Cauwenberge PB, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl): s147-s334
15. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003; 58: 672-675
16. Feinstein AR, Horwitz RI. Problems in the "evidence" of "evidence-based medicine". Am J Med 1997; 103: 529-535
17. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322
18. Heinrich J, Richter K, Frye C, Meyer I, Wolke G, Wjst M, Nowak D, Magnussen H, Wichmann HE. [European Community Respiratory Health Survey in Adults (ECRHS)], Pneumologie 2002; 56: 297-303
19. Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, Jarvis D, Kuenzli N, Leynaert B, Luczynska C, Neukirch F, Svanes C, Sunyer J, Wjst M. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18: 598-611
20. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836
21. Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH, Lanier BQ, Penna P. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007; 136: S107-124
22. Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy 2007; 62: 1057-1063
23. Mösges R, Klimek L. Today's allergic rhinitis patients are different: new factors that may play a role. Allergy 2007; 62: 969-975
24. Mösges R, Koberlein J. [New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis]. HNO 2007; 55: 457-464
25. Ollenschläger G, Kirchner H, Fiene M. Leitlinien in der Medizin - scheitern sie an der praktischen Umsetzung? Internist 2001; 42: 473-483
26. Ring J, Fuchs T, Schultze-Werninghaus G. Weißbuch Allergie. München: Urban & Vogel, 2004
27. Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003; 21: 116-122
28. Wang DY, Niti M, Smith JD, Yeoh KH, Ng TP. Rhinitis: do diagnostic criteria affect the prevalence and treatment? Allergy 2002; 57: 150-154
29. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225-1232
30. Bachert C. Leitlinie zur allergischen Rhinokonjunktivitis. Allergologie 2003; 26: 133-134